Company Overview of Miltenyi Biotec GmbH
Miltenyi Biotec GmbH develops and manufactures cell labeling reagents, cell separation and analysis devices, and systems for clinical applications globally. Its products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation, and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research; and clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration, and freezing products. The company was founded in 1989 and is based in Bergisch Gladbach, Germany with additional offices ...
Bergisch Gladbach, 51429
Founded in 1989
Key Executives for Miltenyi Biotec GmbH
Global Head Clinical Products
General Manager of Gangnam District for Seoul
Compensation as of Fiscal Year 2014.
Miltenyi Biotec GmbH Key Developments
Miltenyi Biotec Opens New Office in South Korea; Appoints Daesuk Oh as General Manager of New Office
Jun 27 13
Miltenyi Biotec announced that it opened a new office in Seoul, Korea, enlarging the company's Asia-Pacific presence to six locations in five countries.
Daesuk Oh has been appointed General Manager of the new office in the Gangnam district of Seoul.
Miltenyi Biotec Obtains License to Manufacture MB101 Antibody in Germany
Jun 26 13
The Arzneimittelüberwachungsbehörde of Mecklenburg-Vorpommern and the Paul-Ehrlich-Institut (PEI), the German medical regulatory authorities, have granted manufacturing license for therapeutic antibody MB101 to Miltenyi Biotec. The license allows the company to manufacture the humanized, monoclonal antibody under recombinant conditions in a mammalian cell line (CHO cells) in its GMP facility in Teterow, Germany. Vital MB101 project activities such as antibody engineering and humanization, cell line development, GMP-compliant manufacturing of drug substance and drug product, QC testing, antibody characterization, and stability studies were all accomplished at the facility.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries